NorthCoast Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
NorthCoast Asset Management's GILD Position: Q3 2021 in Review
NorthCoast Asset Management increased its Gilead Sciences (GILD) stake by 2.4% in Q3 2021, buying an estimated $8.64K and bringing the position to 5,212 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #372.
NorthCoast Asset Management first reported a position in GILD in Q2 2013 and has held it in 20 quarters since. The position peaked at $77.6M in Q1 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.
- NorthCoast Asset Management held 5,212 shares of Gilead Sciences worth $364K as of Q3 2021.
- NorthCoast Asset Management bought 123 Gilead Sciences shares in Q3 2021, an estimated $8.64K.
- Gilead Sciences made up 0.01% of NorthCoast Asset Management's portfolio in Q3 2021, its #372 holding.
- NorthCoast Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 20 quarters since.
- NorthCoast Asset Management's Gilead Sciences position peaked at $77.6M in Q1 2015.
- 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.
Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.